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ABSTRACT
In synthesizing a double-stranded DNA from vi-
ral RNA, HIV-1 reverse transcriptase (RT) gener-
ates an RNA/DNA intermediate. RT also degrades
the RNA strand and synthesizes the second DNA
strand. The RNase H active site of RT functions as
a nuclease to cleave the RNA strand; however, the
structural basis for endonucleolytic cleavage of the
RNA strand remains elusive. Here we report crystal
structures of RT-RNA/DNA-dATP and RT-RNA/DNA-
nevirapine (NVP) ternary complexes at 2.5 and 2.9
A˚ resolution, respectively. The polymerase region
of RT-RNA/DNA-dATP complex resembles DNA/DNA
ternary complexes apart from additional interactions
of 2′-OH groups of the RNA strand. The conformation
and binding of RNA/DNA deviates significantly after
the seventh nucleotide versus a DNA/DNA substrate.
Binding of NVP slides the RNA/DNA non-uniformly
over RT, and the RNA strand moves closer to the
RNase H active site. Two additional structures, one
containing a gapped RNA and another a bulged RNA,
reveal that conformational changes of an RNA/DNA
and increased interactions with the RNase H domain,
including the interaction of a 2′-OH with N474, help
to position the RNA nearer to the active site. The
structures and existing biochemical data suggest a
nucleic acid conformation-induced mechanism for
guiding cleavage of the RNA strand.
INTRODUCTION
HIV-1 reverse transcriptase (RT) is a central enzyme re-
sponsible for copying the viral single-stranded RNA (ss-
RNA) into a double-stranded DNA (dsDNA) in the cyto-
plasm of an infected cell (1–3). This event occurs after a
virus infects a cell. The synthesized viral dsDNA is trans-
ported into the nucleus as a pre-integration complex, and
subsequently integrated into the chromosome of the in-
fected cell. Copying of viral RNA to dsDNA involves sev-
eral steps (4), namely: (i) annealing of a host tRNALys,3,
complementing the primer-binding sequence of the viral ss-
RNA, forms a double-stranded nucleic acid segment that
binds RT to initiate RNA-dependent DNA polymerization;
(ii) RT adds nucleotides complementing the (+)RNA strand
to synthesize (−)DNA strand starting from the 3′-end of
the annealed tRNA; (iii) RNase H activity of RT degrades
RNA strand from RNA/DNA hybrid leaving short A-T
rich segments, known as polypurine tracts (PPTs), attached
to the (−)DNA strand and (iv) the (+)DNA strand synthe-
sis is initiated from the 3′-end of a PPT segment. A non-PPT
RNA is usually cleaved in a non-sequence-specific manner.
However, the presence of specific nucleotides at positions
adjacent to the RNase H site and distal sites in the nu-
cleic acid-binding cleft of RT can enhance RNase H cleav-
age efficiency (5). The rate of RNase H cleavage is slower
than polymerization by RT (6,7). Unlike nucleotide addi-
tion by RT, which progresses with incorporation of one nu-
cleotide at a time, the RNase H cleaves discrete phospho-
diester bonds of the RNA strand from an RNA/DNA du-
plex (8–10), i.e. HIV-1 RNase H acts as an endonuclease
rather than as an exonuclease enzyme. Biochemical studies
have revealed that RT degrades the RNA strand by com-
binations of primer-dependent primary cuts and primer-
independent secondary cuts (11); see reviews by Schultz and
Champoux (12) and Beilhartz and Gotte (13). The primary
cut of an RNA strand occurs about 18 nucleotides away
from the polymerase active site for which the RNA/DNA
would occupy the entire nucleic acid cleft extending from
the polymerase site to the RNase H site. Sliding of RT over
an RNA/DNA substrate (14,15) might facilitate the sec-
ondary cleavages. However, the detailed structural bases for
both the primary and the secondary cleavages remain elu-
sive.
*To whom correspondence should be addressed. Tel: +1 732 235 5323; Fax +1 732 235 5788; Email: arnold@cabm.rutgers.edu
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at R
utgers U
niversity Libraries/Technical Services on July 30, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
8126 Nucleic Acids Research, 2014, Vol. 42, No. 12
The DNA polymerization activity of RT has been a
central drug target for anti-AIDS therapy. Thirteen RT
inhibitors (eight nucleoside/nucleotide inhibitors, NRTIs;
five non-nucleoside RT inhibitors, NNRTIs) are approved
for treating HIV-1 infection. In contrast, the RNase H ac-
tivity has not yet been successfully targeted for blocking vi-
ral replication. HIV-1 RNase H has a two cation-dependent
nuclease activity (16), and the enzyme shares an active site
architecture (17) that is conserved in RNase H enzymes in
bacteria (18), human (19) and functionally related enzymes
like Argonaute (20). The HIV-1 integrase active site also
shares a common active site geometry with HIV-1 RNase
H. Therefore, both enzymatic activities of HIV-1 are inhib-
ited by common classes of metal-chelating small-molecule
inhibitors such as diketo acid derivatives (21–23). Metal-
chelating inhibitors have been successfully optimized to de-
velop the integrase-inhibiting anti-AIDS drugs raltegravir,
dolutegravir and elvitegravir. However, analogous efforts in
optimizing active-site metal-chelating RNase H inhibitors
into drug candidates have not yet been successful, presum-
ably due to inability in attaining significant binding speci-
ficity and affinity for the compounds against the HIV-1
RNase H site beyond the metal chelation (24–27). Speci-
ficity and activity also differ among RNase H enzymes; for
example, Escherichia coli RNase H is a functionally inde-
pendent enzyme, whereas the HIV-1 RNase H domain re-
quires additional elements from the polymerase domain for
RNase H cleavage activity (28). The RNase H domain of a
closely related retrovirus, Moloney murine leukemia virus,
was shown to be active; however, the polymerase domain is
required for providing specificity for the cleavage of RNA
from an RNA/DNA duplex (29,30). Taken together, these
studies imply that RNA degradation byHIV-1 RT is a com-
plex process that involves structural elements beyond the
RNase H domain to guide the RNA strand to the RNase H
active site, even though the mechanism of catalytic cleavage
of phosphodiester bonds is conserved among RNase H and
related enzymes.
Structurally, RT is a heterodimer of p66 and p51 polypep-
tide chains. The p66 subunit contains both the polymerase
and RNase H active sites. The p51 subunit is proteolytically
derived from a p66 chain by HIV-1 protease cleaving off the
C-terminal RNase H domain; p51 plays a structural role.
RT is a highly flexible enzyme that undergoes conforma-
tional changes to carry out its activity. Several conforma-
tional and functional states of RT have been structurally
characterized (31). While most RT structures are in com-
plexes with an NNRTI or with DNA/DNA that predomi-
nantly elucidate DNA-dependent DNA polymerization, in-
hibition and resistance activities around the polymerase ac-
tive site, only two publications have reported structures of
complexes of HIV-1 RT with RNA/DNA. The structure of
a (PPT) RNA/DNA in complex with RT at 3 A˚ resolution
showed base-pairing mismatches in the AT-rich region, and
the report suggested that the meltdown may have a role in
keeping the RNA strand away from the RNase H active site
for this PPT template-primer (32). This study also identi-
fied the ‘RNase H primer grip’ as a structural element in
p66 that binds the DNA primer strand in the vicinity of the
RNase H region. A recent structural study shows a signifi-
cantly different track for RNA/DNA compared to those in
all remaining RT-nucleic acid complex structures (33); the
highest resolution structure at 3.3 A˚ has a nick in the mid-
dle of the RNA strand and the other two structures were
determined at∼5 A˚ resolution. However, in both of the RT-
RNA/DNA structures (32,33), the RNA strand does not
reach the RNase H active site. Therefore, the structural ba-
sis for the mechanism by which an RNA strand reaches the
RNase H active site for catalytic RNA degradation remains
elusive even 20 years after the first structures of HIV-1 RT
were reported (34,35).
Here we report four structures of HIV-1 RT-RNA/DNA
complexes in the presence of either a dATP substrate or
an NNRTI drug, nevirapine (NVP); the RNA/DNA se-
quences used in the current study are shown in Figure
1A–C. The RT-RNA/DNA-dATP structure determined at
2.5 A˚ resolution, the highest resolution for an RT-nucleic
acid complex, defines the binding of an RNA/DNA sub-
strate to RT and reveals distinctions relative to binding of
DNA/DNA duplexes. A systematic analysis of this series
of RT-RNA/DNA structures reveals multiple conforma-
tional states of RNA/DNA, suggesting that a nucleic acid
conformation-induced mechanism could be responsible for
regulating sporadic cleavages of the RNA strand by RT.
MATERIALS AND METHODS
RT expression, RT-RNA/DNAcross-linking and purification
of complexes
HIV-1RT construct RT127A containing anRNaseH active
site mutationD498N and a thumbmutation Q258C for RT-
RNA/DNA cross-linking was cloned, expressed and pu-
rified following a previously reported protocol (36). The
RNA/DNA template-primer sequences used in the current
study are shown in Figure 1. The cross-linkable 20-mer
DNA primer was custom synthesized (37), and the RNA
templates [27-mer RNA, 27-mer bulged RNA (bulgeRNA)
and 12- plus 14-mer gapped RNA (gapRNA)] were syn-
thesized by Dharmacon and Integrated DNA Technolo-
gies. Each annealed template-primer was cross-linked to
RT127A at the mutated Q258C site of p66, followed by ex-
tension with a ddG at the 3′ end through RT polymeriza-
tion, and the individual complexeswere purified using a tan-
dem Ni-NTA and heparin column as previously described
(38). To remove the His tag, the RT-RNA/DNA complexes
were treated with human rhinovirus 14 3C protease.
Crystallization and crystal soaking
RT-RNA/DNA-dATP crystals. The RT-RNA/DNA bi-
nary complex was concentrated to 9 mg/ml in 75 mMNaCl
and 10 mM Tris pH 8.0. Crystals were grown at 4◦C by
hanging-drop vapor diffusion against well solution contain-
ing 50 mM bis-tris propane-HCl pH 7.0, 10% PEG 8000
(w/v), 100 mM ammonium sulfate, 5% glycerol (v/v), 5%
sucrose (w/v) and 20 mM MgCl2. The crystals were taken
out of the drop and transferred to a stabilization solution
containing 1.5 l of 50 mM bis-tris propane pH 7.0, 14%
PEG8000 (w/v), 20mMMgCl2, 5% sucrose (w/v), 5% glyc-
erol (v/v) and 100 mM ammonium sulfate for 10 min. The
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Figure 1. RNA/DNA constructs and the crystal form used in the current study of structures of HIV-1 RT-RNA/DNA complexes. (A) Sequences of a
27/21-mer RNA/DNA used in the structural study of RT-RNA/DNA-dATP (or NVP) complex; the nucleotides are numbered at frequent intervals,
and the blue arrow indicates the RNase H cleavage position on the RNA strand. A gapped RNA (B) and a bulged RNA (C) used in the structural
studies. The positions of a designed bulge (A) or a gap (−) are shown in red in the two sequences below. (D) Crystal packing in the current crystal form
shows no significant crystal contacts involving the RNA/DNA template-primers, permitting systematic comparison of conformational changes of RT and
RNA/DNA associated with binding of a dNTP or an NNRTI in crystals.
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crystals were then treated for 15 min in a solution contain-
ing 5 mM dATP, 14% PEG 8000 (w/v) and 1 mM MgCl2
for forming the RT-RNA/DNA-dATP complex in crystals.
The crystals were cryoprotected by dipping for 1 min into
the above solution with glycerol concentration increased to
20% (v/v), and flash frozen in liquid N2.
RT-RNA/DNA-NVP crystals. The RNA/DNA,
gapRNA/DNA and bulgeRNA/DNA complexes were
buffer exchanged and concentrated to 12 mg/ml in 75
mM NaCl and 10 mM Tris-HCl pH 8.0. The crystals were
grown at 4◦C in sitting drops, by vapor diffusion against
well solution containing 50 mM bis-tris propane pH 7.2 –
7.4, 9 – 11% PEG 8000 (w/v), 100 mM ammonium sulfate,
5% glycerol (v/v), 5% sucrose (w/v) and 20 mMMgCl2.
Crystals of RT-RNA/DNA complex were transferred
stepwise into 200 l of solution I [50 mM bis-tris propane-
HCl pH 7.4, 100 mM ammonium sulfate, 5% sucrose (w/v),
10% (v/v) glycerol and 12% (w/v) PEG 8000] for 30 min
to remove Mg2+ ions, then into 50 l of solution II [so-
lution I containing 2 mM NVP and 4% DMSO (v/v)] for
3 h 30 min and finally into 10 l solution III [solution II
with glycerol concentration increased to 20%] for 1.5 min.
The RT-RNA/DNA-NVP crystals harvested from solution
III were flash frozen in liquid N2. A similar procedure was
followed to obtain the crystals of RT-bulgeRNA/DNA-
NVP or RT-gapRNA/DNA-NVP complexes (Figure 1A–
C). Two millimolar of CaCl2 was added to solutions II and
III for the soaking of RT-bulgeRNA/DNA and 2 mM of
MnSO4 was added to solutions II and III for the soaking of
RT-gapRNA/DNA crystals, respectively.
Data collection, processing and structure determination
Flash-frozen crystals were transported to the F1 beam line
at the Cornell High Energy Synchrotron Source (CHESS).
X-ray diffraction data were collected from a 280 × 120 ×
30 m3 crystal of RT-RNA/DNA-dATP, a 200 × 200 ×
60 m3 crystal of RT-DNA/RNA-NVP, a 280 × 120 ×
30 m3 crystal of RT-gapRNA/DNA-NVP and a 240 ×
120 × 40 m3 crystal of RT-bulgeRNA/DNA-NVP com-
plex. Individual datasets were processed and scaled using
HKL2000 (39) (Table 1). The diffraction data were severely
anisotropic, and the datasets were corrected for anisotropy
using theUCLAMBI –DiffractionAnisotropy Server (40).
Atomic coordinates of an RT molecule in RT-DNA/DNA-
AZTTP (PDB ID 3V4I) or RT-DNA/DNA-NVP (PDB
ID 3V81) complexes (37) were used as starting models to
locate the two copies of RT in RT-RNA/DNA-dATP or
RT-RNA/DNA-NVP complexes, respectively, by molecu-
lar replacement. The initial orientations and positions of
individual subdomains (fingers, palm, thumb and connec-
tion) and RNase H domain were ascertained by rigid-body
refinements of the structural segments of the individual
starting models from molecular replacement solutions. The
positions and conformations of RNA/DNA, dATP and
NVP in the structures were identified and built into dif-
ference Fourier maps calculated prior to inclusion of the
respective structural elements in refinements. The struc-
tures were refined using PHENIX (41) and atomic models
were rebuilt using Coot (42) in cycles. Because of notice-
able structural differences between the two copies of each
complex per crystallographic asymmetric unit (Figure 1D),
no non-crystallographic restraints were used in the refine-
ment of any of the structures. Final refinement statistics for
the structures are listed in Table 1. The figures were gen-
erated using PyMol (http://www.pymol.org/) or ChemBio-
Draw (http://www.cambridgesoft.com/).
RESULTS
Structure of RT-RNA/DNA-dATP complex
RT undergoes conformational changes involving hinge mo-
tions between subdomains for carrying out its multiple
functions. Crystal structures have revealed the structural
and conformational changes of RT upon binding of a
double-stranded nucleic acid, a dNTP or an NNRTI (31).
We have discovered a crystal form of RT-nucleic acid com-
plex (Figure 1D) in which RT molecules are well separated
by disordered solvent regions (channels), permitting visu-
alization of large conformational changes and hinge mo-
tions of RT in crystals (37). This flexibility of RT molecules
in a crystal permitted (i) the binding of a dNTP to form
a catalytic RT-RNA/DNA-dATP polymerase complex or
(ii) the binding of NVP to form NNRTI-inhibited RT-
RNA/DNA-NVP ternary complex. The structures of the
dATP- and NVP-ternary complexes were determined at 2.5
and 2.9 A˚, respectively. 2.5 A˚ resolution corresponds to
the highest detail for an RT-nucleic acid complex structure
reported so far, permitting reliable definition of the posi-
tion, conformational state and interactions of individual
nucleotides of the RNA/DNA substrate (Figure 2A).
In the RT-RNA/DNA-dATP complex, the dATP sub-
strate binds near the polymerase active site in a mode simi-
lar to that in an analogousRT-DNA/DNA-dATP complex,
earlier obtained in a different crystal form (43). Addition-
ally, the current structure reveals the binding of dATP in-
volving two divalent cations that chelate three catalytic as-
partates (D110, D185 and D186); the side chain of the third
catalytic aspartate (D186) is involved in chelation of metal
ion A (Figure 2B). An RNA/DNA binds RT with a higher
affinity than a DNA/DNA template-primer, attributable to
the additional interactions of 2′-OH groups of the RNA
template with the polymerase domain (44). In the crystal
structure, (i) the 2′-OH of the first nucleotide overhang (-
1; Figure 1A), complementing the dATP, forms a hydro-
gen bond with the main-chain carbonyl oxygen of G152; (ii)
residues Q151 and G152 form a part of the dNTP-binding
pocket (Figure 2B) and (iii) the 2′-OH of the second nu-
cleotide overhang (–2) interacts with the side chain of D76,
a conserved residue at the base of the functionally critical
3−4 sheet that rearranges to assist dNTP binding. These
additional interactions of RNAwith the ‘template grip’ (35)
may also account for the higher fidelity of RNA-dependent
DNA polymerization compared to DNA-dependent DNA
polymerization by RT (45,46). These interactions between
the 2′-OH groups of RNA template and RT are also con-
served in a recently reported structure of an RNA/DNA in
complex with the polymerase domain of Moloney murine
leukemia virus (47).
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Table 1. X-ray data and refinement statistics
RT-RNA/DNA-
dATP
RT-RNA/DNA-
NVP
RT-gapped
RNA/DNA-NVP
RT-bulged RNA/
DNA-NVP
PDB ID 4PQU 4PUO 4Q0B 4PWD
Data collection
Space group P21 P21 P21 P21
Cell dimensions
a, b, c (A˚) 89.44, 128.29, 130.68 89.74, 132.13, 141.96 89.72, 131.05, 141.63 89.68, 130.77, 141.87
, ,  (◦) 90, 101.76, 90 90, 100.63, 90 90, 100.69, 90 90, 100.75, 90
Resolution (A˚) 50.0–2.5 (2.54 –2.5)* 50.0–2.9 (2.95 – 2.9) 50–3.3 (3.36 – 3.3) 50.0 – 3.0 (3.05 – 3.0)
Rmerge 0.102 (0.532) 0.093 (0.687) 0.142 (0.670) 0.097 (0.669)
I / (I) 9.7 (1.8) 8.8 (1.3) 7.0 (1.4) 10.3 (1.6)
Completeness (%) 98.4 (96.7) 98.8 (94.3) 98.6 (97.6) 96.2 (90.9)
Redundancy 3.6 (3.0) 3.5 (2.7) 3.0 (2.5) 3.6 (3.0)
Refinement
Resolution (A˚) 40.5 – 2.5 46.5 – 2.9 46.4 – 3.3 44.7 – 3.0
Cut-off criteria F ≤ 1.4 F ≤ 0 F ≤ 0 F ≤ 0
No. reflections (Rfree
set)
96 925 (2922) 70 967 (2135) 47 845 (1419) 61 963 (1837)
Rwork / Rfree 0.202/0.266 0.228/0.285 0.237/0.317 0.221/0.291
No. atoms:
Protein+DNA 17 300 17 427 17 3781 17 461
Ligand/ion/solvent 60/4/450 40 40/2/5 40/2
Stereochemistry
(RMSDs)
Bond lengths (A˚) 0.01 0.015 0.013 0.015
Bond angles (◦) 1.26 1.79 1.77 1.65
One crystal was used for each data set. *Values in parentheses are for highest-resolution shell.
Apart from the 2′-OH interactions, the nucleic acid and
dNTP superimpose well at and around the polymerase ac-
tive site when the RNA/DNA complex is compared with
RT-DNA/DNA-dNTP ternary complexes (37,43,48–49).
However, moving towards the RNase H active site, the
nucleic acid track for RNA/DNA deviates significantly
fromDNA/DNA (Figure 2C): the minor groove width sug-
gests an A-like form for RNA/DNA and a B-like form for
DNA/DNA in this region. The sugar-phosphate backbone
of the first five nucleotides from the polymerase active site
of both the RNA and DNA templates superimposes, and
the sugar rings in both have C3′-endo (A-form) conforma-
tion. The puckering of the sugar rings and consequently the
positions of phosphates start diverging from the seventh nu-
cleotide (Figure 2C); the ribose rings of the RNA template
in the RT-RNA/DNA-dATP complex maintain C3′-endo
conformation, whereas the deoxyribose rings of the DNA
template start switching conformation away fromC3′-endo.
The average inter-base-pair parameters (SupplementaryTa-
ble S1), however, suggest no distinct differences between the
RT-bound RNA/DNA and DNA/DNA conformations.
The two copies of the RT-RNA/DNA-dATP complex in
the crystal asymmetric unit (Figure 1D) have similar over-
all structure and RNA/DNA conformation; however, the
local structures and thermal vibrations (B-factors) differ,
reflecting significant flexibility and adaptability of RT and
RNA/DNA captured by the current crystallography exper-
iments (Supplementary Figure S1). The RNA/DNA du-
plex maintains A-form geometry, whereas the conforma-
tion of DNA/DNA duplex in an analogous crystal form
(37) differs for the stretch extending towards RNase H ac-
tive site (Figure 2D). In contrast to an A-like conformation
of regular RNA/DNA in the current structure, the (PPT)
RNA/DNA in the earlier published structure (32) has non-
A form geometry in this region, which may be a reason that
RT does not recognize a (PPT) RNA/DNA as a substrate
for RNase H cleavage. However, the scissile phosphodiester
bond is not positioned appropriately at the RNase H ac-
tive site of the current 2.5 A˚ RT-RNA/DNA-dATP struc-
ture, and thus does not represent the conformational state
of an RNase H catalytic complex. The structure reveals a
polymerase-competent mode of RT using an RNA/DNA
template-primer; however, the RNA/DNAmay need to un-
dergo conformational changes to interact with the RNase
H active site for cleavage of the RNA strand. Binding of
an NNRTI enhances RNase H cleavage activity (14), there-
fore it is plausible that the RNA strand may be guided to-
wards the RNase H active site in the structure of an RT-
RNA/DNA-NNRTI complex.
Structure of RT-RNA/DNA-NVP complex
Binding of NVP to RT-RNA/DNA complex was accom-
panied by significant changes, predominantly involving re-
arrangements of the subdomains and repositioning of the
RNA/DNA away from the polymerase active site. Anal-
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Figure 2. Structure and conformation of RT-RNA/DNA-dATP complex. (A) A stereoview of the electron density (2Fo-Fc) calculated at 2.5 A˚ resolution
defines the binding track and conformation of RNA/DNA bound to RT. (B) A stereoview showing the binding of dATP in a polymerase catalytic mode.
The binding involves chelation of twoMg2+ ions (A and B) with the catalytic aspartic acid residues (D110, D185 and D186); the metal ions chelate all three
phosphates of dATP (green). ‘W’ represents the only water molecule involved in the metal chelation. Use of a 3′-dideoxy-terminated primer prevents the
catalytic incorporation of the nucleotide. (C) Comparison of the modes of binding of RNA/DNA (yellow spokes) versus DNA/DNA [cyan spokes, PDB
ID. 3V4I (37)] to HIV-1 RT (gray surface) in the respective catalytic ternary complexes shows significant deviations in nucleic acid binding tracks away
from the polymerase active site. The structures of RT-RNA/DNA-dATP and RT-DNA/DNA-dATP [PDB ID. 3V4I (37)] were aligned by superimposing
C atoms of RT. A zoomed view of the RNA template illustrates the differences in sugar conformations and phosphate positions after the fifth nucleotide
from the polymerase active site. Differences in sugar ring conformations between RNA versus DNA template account for the divergent binding tracks of
RNA/DNA (yellow) versus DNA/DNA (cyan) following the seventh nucleotide. (D) Minor groove width (y-axis in A) analysis of the two independent
copies of DNA/DNA (blue and cyan) versus two independent copies of RNA/DNA (yellow and orange) in crystallo using CURVES+ (53) shows that
the RT-bound RNA/DNAmaintains A-like conformation, whereas the DNA/DNA deviates away from A-like conformation beyond the polymerase site.
The RNase H cleavage site is indicated by a red arrow on the x-axis.
ogous to what was observed in the formation of an RT-
DNA/DNA-NVP complex (37), the RNA/DNA duplex is
shifted away from the polymerase active site; consequently,
the distorted dNTP-binding site does not accommodate a
dNTP. Consistent with these observations, a recent isother-
mal titration calorimetry study demonstrated the inability
of an RT-DNA/DNA-NNRTI complex to bind a dNTP
substrate in solution (50).
When the two copies of RT-RNA/DNA-NVP com-
plex in the crystal are compared, the NVP binding site is
highly superimposible; however, the RT subdomains are
rearranged a little differently in one copy (Mol-1) com-
pared to the other (Mol-2). Differences in subdomain ar-
rangements are also observed from comparison of mul-
tiple crystal structures of RT/NVP binary complex; e.g.
PDB IDs 3HVT (34) versus 1RTH (51). In the current RT-
RNA/DNA-NVP structure, the differences in the arrange-
ments of the subdomains impacted the conformation of
RNA/DNA in the two molecules differently. As a conse-
quence, the RNA strands have conformational differences
and are positioned differently with respect to the RNase
H active site in Mol-2 compared to that in Mol-1 of RT-
RNA/DNA-NVP complex in the crystal (Figure 3A–C). In
contrast, the conformation of DNA/DNA (Figure 3D) is
less perturbed upon binding of NVP when previously re-
ported structures of RT-DNA/DNA-NVP (PDB ID 3V81)
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Figure 3. Conformational changes of RNA/DNA upon binding of NVP to RT. (A) Comparison of the binding tracks of RNA/DNA in RT-RNA/DNA-
dATP complex (Mol-1; yellow) and the two independent copies in RT-RNA/DNA-NVP (Mol-1, blue; Mol-2, cyan); the molecular surface of RT inMol-2
is shown in gray. (B) A closer view of the RNase H active site of panel A shows the shift of scissile phosphate towards the RNase H active site, represented
by two metal ions A and B. The metal ions are positioned by aligning the RNase H domain of the structure RT-- thujaplicinol (PDB ID 3IG1) (24)
binary complex with the current structures. The scissile phosphate in the RT-RNA/DNA-NVP complex (Mol-2) is shifted by ∼3.5 A˚ from P to P’, and P’
is positioned almost equidistant from the metal ions A and B; the distances are listed in A. (C) The CURVES+ () analysis of minor groove width (y axis in
A) of RNA/DNA in the two independent copies of RT-RNA/DNA-dATP (yellow and orange) and RT-RNA/DNA-NVP (blue and cyan) structures; the
RNA/DNA conformation superimposes well in RT-RNA/DNA-dATP copies, however, deviates upon NVP binding. (D) In contrast to RNA/DNA, the
conformation of DNA/DNA is influenced significantly less by NNRTI binding (53). The minor groove widths of two independent copies of DNA/DNA
in RT-DNA/DNA-NVP (yellow and orange; PDB ID 3V81) and RT-DNA/DNA-AZTTP (blue and cyan; PDB ID 3V4I) structures by CURVES+ are
plotted.
and RT-DNA/DNA-AZTTP (PDB ID 3V4I) obtained in
an analogous crystal form were compared (37).
In structures of HIV-1 RT in complexes with RNase H
inhibitors, the inhibitors chelate both RNase H active site
cations (24–26). We aligned the RNase H domain of the
HIV-1 RT/- thujaplicinol structure (PDB ID 3IG1) (24)
to position the two cations approximately at the RNase H
active site of the current RT-RNA/DNA-NVP structure.
Based on the above superposition of RNase H domains, the
18th template phosphate (Figure 1A) is positioned almost
equidistantly from the two cations (Figure 3B); a phos-
phate oxygen is positioned ∼5.7 and 5.9 A˚ away from both
metal ions. In light of these considerations, bending of the
RNA/DNA towards the active site would be required to
bring the phosphate oxygen closer (∼2.5 A˚) for chelation
with the metal ions. This could be achieved by conforma-
tional changes of RNA/DNA, as discussed later.
Protein–nucleic acid interaction and crystallographic B-
factor analyses of dATP and NVP complexes suggest that
the binding of RNA/DNA to RT is primarily defined by
its interactions with palm, thumb and finger subdomains
in the polymerase domain, and with the RNase H primer
grip in and nearby the RNase H domain (32). The parts
of RNA/DNA that interact with RT have relatively lower
B-factors (Supplementary Figure S1), and non-interacting
parts have higher flexibility and higher B-factors despite
the fact that RT-RNA/DNA homogenous complex was
formed by cross-linking the DNA primer with RT, i.e. RT
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andRNA/DNAretain conformational flexibility in theRT-
RNA/DNA cross-linked complex used in the current study.
The RNase H primer grip is important for degradation
of RNA by RT, and mutations of the primer grip residues
cause significant loss of RNase H cleavage activity (52).
When compared with the dATP ternary complex, the phos-
phate group slides laterally ∼3.5 A˚ towards the RNase H
active site upon binding of NVP (Figure 3B) in the NVP
ternary complex. The sliding is not uniform, however, for
both the RNA template and DNA primer strands (Figure
3A and B). Interactions with the RNase H primer grip sta-
bilize the DNA strand; the interacting part of the DNA
has the lowest B-factors compared to the remaining parts
of the RNA/DNA in the NVP complex (Supplementary
Figure S1). A non-uniform slide is apparently responsible
for the base-pair meltdown and conformational distortion
of RNA/DNA positioned in the region between the poly-
merase andRNaseH sites where RNA/DNAdoes not have
significant interaction with RT. Analysis of nucleic acid du-
plex conformations by CURVES+ (53) reveals significant
deviation of RNA/DNA conformation from A-form (ob-
served in the dATP-complex) for the region in the NVP
complex (Figure 3C). In contrast, NVP binding has sig-
nificantly less impact on DNA/DNA conformation in the
structures obtained earlier in an analogous crystal form (37)
(Figure 3D). This structural finding suggests that an RT-
bound RNA/DNA can undergo conformational changes
induced by binding of an NNRTI or by frequent sliding
of RT over RNA/DNA in the process of nucleotide incor-
poration and translocation. In a biochemical study of an
RT-RNA/DNA-foscarnet ternary complex, in which the
RNA/DNA slides forward to N site (nucleotide-binding
site), the RNase H active site accesses the 19th phosphate
rather than the 18th phosphate of an RT-RNA/DNA com-
plex (54).
An RNA strand of an RNA/DNA duplex is cleaved pe-
riodically. The template RNA strand does not consistently
interact with RT near the RNase H domain, and thereby no
structural element of RT continuously threads the RNA to
the RNase H active site for the cleavage of phosphodiester
bonds. It seems likely that anRNA/DNAduplex constantly
undergoes conformational changes while RT slides over
it (14,15), and conformational changes of an RNA/DNA
may help the RNA strand to reach the RNase H active
site. To investigate the structural requirements for an RNA
strand of RNA/DNA to be cleaved, and to visualize con-
formational changes of RNA/DNA that can occur, we in-
troduced a bulge and a gap in the RNA strand as described
below.
Structures of RT bulged (or gapped) RNA/DNA-NNRTI
complexes
To artificially introduce conformational variations and in-
vestigate the effects on the proximity of the RNA strand
with respect to the RNase H active site, we introduced
(i) a single-nucleotide bulge and (ii) a single-nucleotide
gap in the RNA strand of the RNA/DNA duplex (Fig-
ure 1B and C). Following the experimental procedures used
for obtaining the previously described complexes, crystals
of RT-bulged RNA/DNA (bulgeRNA) and RT-gapped
RNA/DNA (gapRNA) complexes were obtained in the de-
scribed crystal form (Figure 1D), permitting the forma-
tion of respective NVP complexes by soaking the NNRTI
into crystals as outlined in the Materials and Methods sec-
tion. Like in the RT-RNA/DNA-NVP complex, the bulged
RNA/DNA (or the gapped RNA/DNA) template-primers
have conformational differences when the two copies (Mol-
1 and Mol-2) in the crystallographic asymmetric unit of a
bulgeRNA (or gapRNA) complex are compared (Supple-
mentary Figure S2). In crystals, the RNA/DNA conforma-
tion and binding exhibit wider variations in Mol-2 than in
Mol-1 even though both copies undergo large conforma-
tional changes upon binding of an NNRTI. Hereafter, we
will primarily compare and discuss Mol-2 structures of the
RNA/DNA complexes unless otherwise stated.
The structures of gapRNA-NVP and bulgeRNA-NVP
complexes were determined at 3.2 and 3.0 A˚ resolution,
respectively (Table 1). As designed, the gap and the bulge
on the RNA strands are in the region that does not inter-
act with RT (Figures 1B, C and 4A). The gapRNA or bul-
geRNA structures show variations in the RNA/DNA con-
formation when compared with each other or with the RT-
RNA/DNA-NVP complex (Figure 4B). The introduced
conformational perturbations impact the positioning of the
RNA strand adjacent to the RNase H active site. Interest-
ingly, both a gap and a bulge in the RNA strand help move
the scissile phosphate group closer towards the RNase H
active site (Figure 4C and D).
Mg2+ ions are the cofactors for RNase H activity in vivo.
However, structures of inhibitors chelated at the RNase H
active site of RT could only be obtained in the presence of
Mn2+ ions (24–26), despite many attempts to obtain struc-
tures with Mg2+. Mn2+ or Ca2+ have been substituted for
Mg2+ in structural studies ofRNA/DNA-bound complexes
of related enzymes (19). In our attempts to generate and vi-
sualize metal chelation at the RNase H active site, we in-
troduced Mn2+ or Ca2+ ions into the complexes. Mn2+ or
Ca2+ ions were introduced into the crystals of gapRNA
or bulgeRNA complexes, respectively, by soaking, as de-
scribed in Materials and Methods. Only one ion (Mn2+ or
Ca2+) is observed bound at position A at the RNase H ac-
tive site, and no binding was observed at position B (24).
The scissile phosphate is positioned at an interacting dis-
tance of ∼3.6 A˚ from anMn2+ ion and ∼4.0 A˚ from a Ca2+
ion bound at the RNase H active site in the gapRNA and
bulgeRNA complexes, respectively. This closer proximity of
the RNA strand is accompanied by a significant shift of
the 17th template phosphate (Figure 4C and D) and nar-
rowing of the RNA/DNA minor groove adjacent to the
RNase H active site (Figure 4B). The phosphates of the
DNA primer strand interacting with the RNase H primer
grip, however, are relatively unperturbed (Figure 4A). A
closer approach of theRNA strand over theRNaseH active
site is accompanied by enhanced interactions (i) of the 2′-
OH of the 17th nucleotide with the side chain of the RNase
H primer grip residue N474 and (ii) of the phosphate group
of the 17th nucleotide with Y501 of helix B’ (17) (Figure
4E). Residue N474 is a part of the RNase H helix A’ that
contains the catalytic residue E478, and residues T473 and
Q475 (both interact with the DNA primer). The mutation
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Figure 4. Binding of gapRNA/DNAand bulgeRNA/DNA toHIV-1RT in respective RT-RNA/DNA-NVP complexes. (A) Bindingmodes of RNA/DNA
(green), gapRNA/DNA (yellow) and bulgeRNA/DNA (Mol-1, blue;Mol-2, cyan). The structures were aligned based on RNase H superposition (residues
440 – 540). (B) CURVES+ (53) analysis of minor groove width (y axis in A) of two copies of RNA/DNA in structures of the three RT-RNA/DNA-
NVP complexes. (C) A stereoview showing comparison of binding modes of gapRNA/DNA in Mol-1 (gray) versus Mol-2 (yellow). The RNA strand
switches conformation in Mol-2 to permit closer access the RNase H active site. A cation (Mn2+) was found bound to the active site. The side chains of
conserved RNase H active site residues are shown, and important distances are indicated in A˚. (D) A stereoview showing comparison of binding modes of
bulgeRNA/DNA in Mol-1 (blue) versus Mol-2 (cyan) show conformational changes of RNA in Mol-2 leading to closer approach to the RNase H active
site, analogous to gapRNA/DNA in panel C. (E) A view of the above superposition of bulgeRNA/DNA (Mol-1 and Mol-2) from the primer grip shows
enhanced interactions of the RNA strand of Mol-2 with RNase H helices (A’ and B’) including a hydrogen bond of a 2′-OH group with N474.
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N474A reducesRNaseH cleavage, and the doublemutation
N474A+Q475A has an additive effect (52). Both RNase H
helices A’ and B’ are positioned at the minor groove of
RNA/DNAadjacent to the RNaseH active site. Theminor
groove width is significantly reduced when the RNA strand
approaches the RNase H active site, as observed in Mol-2
of gapRNA and bulgeRNA structures (Figures 4B and 5A,
B). These structural findings suggest that certain conforma-
tional states of RT-RNA/DNA complex enhance the inter-
action between the RNA strand and the RNase H helices
such that the RNA strand approaches the RNase H active
site more closely.
Conformational changes and enhanced RNase H interactions
of RNA/DNA facilitate cleavage
The extensive interactions of both the template and primer
strands of a nucleic acid with the polymerase domain pre-
cisely position the primer 3′-end at the polymerase active
site for catalytic incorporation of each nucleotide. In con-
trast, we did not find any structural element of RT that
would systematically thread the RNA strand to the RNase
Hactive site. Preferred nucleotides at positions adjacent and
distal to RNase H site enhance RNA cleavage (5), presum-
ably by influencing the conformation of RNA/DNA to ac-
cess the active site.
Understanding of how the RNA strand of an
RNA/DNA duplex is guided to the RNase H active
site would illuminate the structural basis for RNA cleavage.
The current structures reveal that the dangled RNA strand
over the RNase H domain is primarily supported by
base pairing and base stacking with the complementing
DNA primer, which is held by the conserved interactions
with the RNase H primer grip (32). Thereby, the sugar-
phosphate backbone of the RNA strand can be rearranged
by altering the conformation of the RNA/DNA duplex.
Comparison of Mol-1 and Mol-2 in bulgeRNA-NVP (or
gapRNA-NVP) crystals reveals such rearrangements of the
RNA strand near the RNase H active site (Figure 5A and
B). The closer approach of the RNA strand in Mol-2 is
accompanied by reduced minor groove width (Figure 4B)
and enhanced interactions with the two RNase H helices
A’ and B’ (Figure 4E).
Structural studies of prototype foamy virus integrase
have revealed almost identical positions and chelation en-
vironments for two active site cations when the structures
of intasome and drug complexes were compared (23). HIV-
1 RNase H has an analogous active site architecture and
inhibitor-chelation environment. Superposition of RNase
H domains of an RT-RNase H inhibitor complex (24) with
the current structures provides a logical positional and
chelation environment of two divalent cations at the RNase
H active site (Supplementary Figure S3). The RNase H
superpositions (residues 440–540) of the RT-RNA/DNA
structures, together with the positioning of two catalytic
metal ions, show multiple positions for the scissile phos-
phodiester bond and the phosphate group of the 18th nu-
cleotide, apparently mimicking a trajectory for approach to
the RNase H catalytic site (Figure 5C); the chelating phos-
phate oxygen and the preceding 3′-O are concurrently ap-
proaching the RNase H active site. Presumably, the nega-
tively charged phosphate moiety nearing the RNase H ac-
tive site would favor chelation of two cations, and cleavage
would occur if the RNA strand is oriented and positioned
appropriately for catalysis (Figure 5D). In fact, binding of
the RNaseH inhibitor - thujaplicinol, which has no signif-
icant interactions beyond the active site, is predominantly
guided and stabilized by its interaction with both active site
metal ions (24). The chelating groups of the RNA strand
would be attracted via the metal ions to the RNase H active
site and bind in an analogous fashion.
Catalytic cleavage of the phosphodiester bond alters the
chelation environment and charge distribution at theRNase
H active site, and consequently, the cleaved RNA products
disengage from the RNase H active site even if the RNA
segments at either end of the cleaved phosphodiester bond
remain hybridized to the DNA template. The presence of
the D498N mutation or a non-chelating rotameric confor-
mation of E478 (Supplementary Figure S3) might be pre-
venting the formation of a catalytic complex in the current
structures. Another structural constraint in nearly all crys-
tal structures of RT is the formation of an extended -sheet
involving two RNase H domains of adjacent molecules.
This extended sheet may also restrict the flexibility of RT
to attain an RNase H catalytic complex in crystals.
DISCUSSION
RT is highly dynamic in solution. As revealed by a set
of single-molecule fluorescence resonance energy transfer
studies, conformational heterogeneity of an RT-nucleic acid
complex is (i) increased by the binding of an NNRTI and
(ii) decreased by the binding of a dNTP (15). All struc-
tures of RT-RNA/DNA complexes reported in the current
study are obtained in highly similar chemical and crystallo-
graphic environments, and the RT molecules in the crystals
are well separated by disordered solvent regions, permit-
ting significant conformational changes required for bind-
ing of (i) a dNTP to form a catalytic polymerase complex
or (ii) an NNRTI to form a polymerase-inhibited com-
plex. Thereby, the observed structural and conformational
changes of an RT-RNA/DNA complex are influenced min-
imally by the use of analogous experimental environments,
and thus can be attributed to dNTP or NNRTI binding.
Interestingly, two independent copies of RT-RNA/DNA
complexes (Mol-1 and Mol-2) in crystals (Figure 1D) ex-
hibit (i) a relatively homogenous conformational state in
the dATP-bound structure and (ii) noticeable differences in
NVP-bound structures (Figure 3C). Binding of an NNRTI
causes significant domain rearrangements, which enhance
sliding of the RNA/DNA substrate such that the scissile
phosphodiester bond has better access to the RNase H ac-
tive site (Figure 3B). The sliding of RNA/DNA over RT
is not uniform for both strands, contributing to conforma-
tional variations of the RNA/DNA (Figure 3A–C). The
designed bulge and gap in RNA introduce additional con-
formational perturbations to an RNA/DNA duplex that
might mimic some of the conformational states accompa-
nying uneven sliding motions of RNA/DNA over RT. De-
spite large variations in the conformation and binding of
RNA/DNA to RT in the presence of NVP, the interactions
of the DNA primer strand with the RNase H primer grip
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Figure 5. Structural requirements for an RNA strand to be cleaved by RNase H of HIV-1 RT. (A) The position of bulgeRNA/DNA (blue CPK model)
with respect to the chelated cation (Ca2+ ion at metal A position, magenta) at the RNase H active site of Mol-1; the RNase H domain of RT is represented
with an electrostatic potential surface. (B) The RNA/DNA (cyan CPK model) is folded towards the RNase H active site in Mol-2. (C) Superposition of
gapRNA (Mol-1, green; Mol-2, yellow) and bulgeRNA (Mol-1, blue, Mol-2, cyan) at the RNase H active site defines a putative trajectory (shown by black
arrows) for the RNA of RNA/DNA duplex reaching the RNase H active site for cleavage. The location of cation B is positioned based on a superposition
of the RNase H domain of RT-- thujaplicinol structure (PDB ID 3IG1)(24). (D) A general catalytic mechanism of cleavage of a phosphodiester bond
by the RNase H activity of HIV-1 RT derived from structural information about nuclease cleavage (16), RNase H cleavage (18) and metal chelation at
the HIV-1 RNase H active site (24). Two additional water molecules and one water molecule would chelate metal ions A and B, respectively, to complete
octahedral coordination environments for both cations.
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remain conserved among the structures. However, the posi-
tions of the complementing nucleotides of the RNA strand
vary when the structures of RT-RNA/DNA-NVP com-
plexes are compared (Figure 4). Conformational changes of
RNA/DNA bring a phosphate oxygen closer to one Ca2+
(or Mn2+) ion present at the RNase H active site in bul-
geRNA or gapRNA structures (with a minimum distance
of ∼4 A˚ between the oxygen and ion) (Figure 4C and D).
Closer approach of the RNA strand towards the RNase H
active site is accompanied by enhanced interaction of the
minor groove of RNA/DNA with the RNase H domain
(Figure 5A and B). Comparison of relative positions of the
RNA strands in the structures of RNA/DNA complexes
reported here shows multiple positions of the scissile phos-
phate with respect to the RNase H active site, and these po-
sitions reveal a possible path for the RNA strand to reach
the active site for cleavage (Figure 5C and D).
A recently reported nicked RNA/DNA-RT-efavirenz
structure shows a significant deviation in the binding of
the RNA/DNA compared to the current structures (Sup-
plementary Figure S4A) and all RT-nucleic acid complexes
previously described in the literature; the authors proposed
that enhanced interaction between the p51 C-terminus and
RNA strand might be critical for RNase H degradation
(33). Our analysis of the structure (PDB ID 4B3O)(33)
suggested that the nicked RNA/DNA is significantly im-
pacted by extensive crystal contacts (Supplementary Fig-
ure S4B), and the interactions of a symmetry-related RT
molecule with RNA/DNA apparently have a major influ-
ence on defining the altered track of the RNA/DNAduplex
approaching the RNase H domain (Supplementary Figure
S4A).
The current series of structures provide insights into how
the non-uniform sliding of RNA/DNA, and conforma-
tional changes of the duplex near to and distal from the
RNase H active site assist the RNA strand in accessing
the active site for cleavage (5,52,54). Further biochemical
and structural experiments guided by the current struc-
tures would help further exploration of binding specificity
of RNAand inhibitors to theRNaseH active sites, andmay
aid design of new RNase H inhibitors.
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